Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation-Reference-Cited by-同舟云学术

Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Published:2014-08 Issue:4 Volume:114 Page:577-582
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Aryal Madan Raj^ORCID,Ukaigwe Anene,Pandit Anil,Karmacharya Paras,Pradhan Rajesh,Mainali Naba Raj,Pathak Ranjan,Jalota Leena,Bhandari Yashoda,Donato Anthony

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Current status and outcomes of catheter ablation for atrial fibrillation;Crawford;Heart Rhythm,2009

2. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis;Santangeli;Circ Arrhythm Electrophysiol,2012

3. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

4. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation;Eitel;Europace,2013

5. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation;Stepanyan;J Interv Card Electrophysiol,2014

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Italian Registry in the Setting of Atrial Fibrillation Ablation with Rivaroxaban - IRIS;Minerva Cardiology and Angiology;2024-05

2. Rationale and study design of the Italian Registry in the setting of Atrial Fibrillation Ablation with Rivaroxaban - IRIS;Minerva Cardiology and Angiology;2023-02

3. Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants;Journal of Chest Surgery;2023-01-30

4. Effect of uninterrupted dabigatran or rivaroxaban on achieving ideal activated clotting time to heparin response during catheter ablation in patients with atrial fibrillation;J GERIATR CARDIOL;2022

5. Direct Oral Anticoagulants and Atrial Fibrillation Ablation;Direct Oral Anticoagulants;2021